FDA Inspection 1232610 — Erik Buntinx, MD
The FDA completed an inspection of Erik Buntinx, MD on Feb 8, 2024 in Diepenbeek. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 8, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Diepenbeek (Belgium)
Additional Details
Clinical Investigator (CI)